Shopping Cart 0
Cart Subtotal
USD 0

Pure Bioscience Inc (PURE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. It develops and markets proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen and hygienic control. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent that provides 24-hour residual protection and formulates well with other compounds. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Pure is headquartered in El Cajon, California, the US.

Pure Bioscience Inc (PURE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical 11

Licensing Agreements 12

Pure Bioscience Enters into Licensing Agreement with Research Instruments 12

Equity Offering 13

PURE Bioscience Raises USD1.5 Million in Private Placement of Shares 13

Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14

Pure Bioscience Raises USD6 Million in Private Placement of Shares 15

Pure Bioscience Completes Public Offering Of Shares For USD 5 Million 16

Pure Bioscience Completes Private Placement Of Shares For USD 1 Million 18

Pure Bioscience Inc-Key Competitors 19

Pure Bioscience Inc-Key Employees 20

Pure Bioscience Inc-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Financial Announcements 22

Jun 13, 2018: PURE Bioscience Reports Fiscal 2018 Third Quarter and Nine-Month Financial Results 22

Dec 14, 2017: PURE Bioscience Reports Fiscal 2018 Q1 Financial Results 23

Mar 02, 2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results 24

Corporate Communications 25

Jul 02, 2018: PURE Bioscience Raises USD 500,000 in Unsecured Promissory Note-Appoints Ivan Chen to Board of Directors 25

Nov 02, 2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant 26

Legal and Regulatory 27

Apr 27, 2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pure Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical 11

Pure Bioscience Enters into Licensing Agreement with Research Instruments 12

PURE Bioscience Raises USD1.5 Million in Private Placement of Shares 13

Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14

Pure Bioscience Raises USD6 Million in Private Placement of Shares 15

Pure Bioscience Completes Public Offering Of Shares For USD 5 Million 16

Pure Bioscience Completes Private Placement Of Shares For USD 1 Million 18

Pure Bioscience Inc, Key Competitors 19

Pure Bioscience Inc, Key Employees 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Pure Bioscience Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. It develops and markets proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen and hygienic control. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent that provides 24-hour residual protection and formulates well with other compounds. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Pure is headquartered in El Cajon, California, the US.

Pure Bioscience Inc (PURE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical 11

Licensing Agreements 12

Pure Bioscience Enters into Licensing Agreement with Research Instruments 12

Equity Offering 13

PURE Bioscience Raises USD1.5 Million in Private Placement of Shares 13

Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14

Pure Bioscience Raises USD6 Million in Private Placement of Shares 15

Pure Bioscience Completes Public Offering Of Shares For USD 5 Million 16

Pure Bioscience Completes Private Placement Of Shares For USD 1 Million 18

Pure Bioscience Inc-Key Competitors 19

Pure Bioscience Inc-Key Employees 20

Pure Bioscience Inc-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Financial Announcements 22

Jun 13, 2018: PURE Bioscience Reports Fiscal 2018 Third Quarter and Nine-Month Financial Results 22

Dec 14, 2017: PURE Bioscience Reports Fiscal 2018 Q1 Financial Results 23

Mar 02, 2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results 24

Corporate Communications 25

Jul 02, 2018: PURE Bioscience Raises USD 500,000 in Unsecured Promissory Note-Appoints Ivan Chen to Board of Directors 25

Nov 02, 2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant 26

Legal and Regulatory 27

Apr 27, 2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pure Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical 11

Pure Bioscience Enters into Licensing Agreement with Research Instruments 12

PURE Bioscience Raises USD1.5 Million in Private Placement of Shares 13

Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14

Pure Bioscience Raises USD6 Million in Private Placement of Shares 15

Pure Bioscience Completes Public Offering Of Shares For USD 5 Million 16

Pure Bioscience Completes Private Placement Of Shares For USD 1 Million 18

Pure Bioscience Inc, Key Competitors 19

Pure Bioscience Inc, Key Employees 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Pure Bioscience Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.